Alemtuzumab for the treatment of multiple sclerosis

By Button Tom   Coles Alasdair J  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 177-188

Future Medicine

Access to resources Recommend Favorite

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

By Linker Ralf A.  

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2248-2263

Oxford University Press

Access to resources Recommend Favorite

Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis

By Ozakbas S.   Cagiran I.   Ormeci B.   Idiman E.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 3-7

Elsevier

Access to resources Recommend Favorite

Contribution of relapses to disability in multiple sclerosis

By Hirst C.   Ingram G.   Pearson O.   Pickersgill T.   Scolding N.   Robertson N.  

Journal of Neurology, Vol. 255, Iss. 2, 2008-02 ,pp. : 280-287

Springer Publishing Company

Access to resources Recommend Favorite

Age at disability milestones in multiple sclerosis

By Confavreux Christian   Vukusic Sandra  

Brain, Vol. 129, Iss. 3, 2006-03 ,pp. : 595-605

Oxford University Press

Access to resources Recommend Favorite